Neuropathology

Historical Context & Motivation

The study of neuropathology arose from the convergence of anatomical investigation, microscopy, and clinical neurology over several centuries. Early physicians recognized that injuries to the brain and spinal cord produced characteristic neurological deficits, yet the cellular and molecular mechanisms underlying these observations remained obscure until advances in tissue fixation, staining, and imaging permitted rigorous examination of nervous tissue. Today, neuropathology is the cornerstone discipline linking clinical neuroscience to histological diagnosis, enabling clinicians to classify neurodegenerative diseases, cerebrovascular events, neoplasms, demyelinating conditions, and infections of the nervous system at both the gross and microscopic levels. For the USMLE Step 1, a working knowledge of neuropathology is essential because exam questions integrate anatomy, physiology, biochemistry, and pharmacology around specific disease processes.

The central question neuropathology addresses is deceptively simple: What cellular and structural changes in nervous tissue produce the clinical deficits we observe? Answering this question requires integrating knowledge of normal neuroanatomy, cellular injury responses (such as Wallerian degeneration and gliosis), vascular supply territories, and the unique vulnerability of neurons to ischemia, toxins, and protein aggregation. The sections that follow systematically build this knowledge base, from foundational principles to clinical correlations tested on Step 1.

Core Principles of Neuropathology

Neuropathology rests on several foundational concepts that distinguish nervous system disease from pathology in other organ systems. The brain's high metabolic demand, limited regenerative capacity, blood-brain barrier, and unique cellular composition (neurons, astrocytes, oligodendrocytes, microglia, ependymal cells) create a distinctive set of injury responses. Understanding these five core principles provides a framework for reasoning through virtually any USMLE neuropathology question.

Visual Explanation — CNS Cellular Responses to Injury

The diagram above captures the essential cellular reactions you must recognize for Step 1. When neurons are deprived of oxygen, they undergo a characteristic sequence: within 12 to 24 hours, the red (eosinophilic) neuron appears with a shrunken, pyknotic nucleus and intensely eosinophilic cytoplasm — this is the earliest histological sign of irreversible neuronal injury. Over the ensuing days to weeks, the infarcted tissue undergoes liquefactive necrosis (unique to the brain, not coagulative as in most other organs), with microglia and recruited macrophages clearing debris and leaving a cystic cavity. Simultaneously, surrounding astrocytes undergo reactive hypertrophy, producing abundant glial fibrillary acidic protein (GFAP), forming a glial scar that walls off the damaged area. In demyelinating diseases such as multiple sclerosis, the myelin sheath is selectively destroyed while the underlying axon may be initially preserved — a distinction with critical implications for clinical reversibility.

Mechanisms of Neural Injury & Disease

Cerebrovascular Disease

Cerebrovascular pathology represents the most tested neuropathology topic on Step 1. Ischemic strokes account for approximately 85% of all strokes and result from thrombotic or embolic occlusion of cerebral arteries. The middle cerebral artery (MCA) is the most commonly affected vessel, producing contralateral hemiparesis and hemisensory loss (face and upper extremity greater than lower extremity), plus Broca or Wernicke aphasia if the dominant hemisphere is involved. Watershed (border zone) infarcts occur between the territories of major arteries during episodes of global hypotension, classically affecting the region between ACA and MCA territories, producing bilateral upper-extremity weakness ('man in a barrel' syndrome). Hemorrhagic strokes include intraparenchymal hemorrhage (most commonly from hypertension, affecting the basal ganglia, thalamus, pons, and cerebellum) and subarachnoid hemorrhage (most commonly from ruptured berry aneurysms at the circle of Willis). The excitotoxicity cascade in ischemic injury involves failure of the Na⁺/K⁺-ATPase, glutamate release, excessive NMDA receptor activation, calcium influx, and activation of caspases and endonucleases leading to apoptosis and necrosis.

Neurodegenerative Diseases

The neurodegenerative diseases share a common pathogenic mechanism: the accumulation of specific misfolded proteins that are toxic to neurons. In Alzheimer disease, amyloid precursor protein (APP) is cleaved by β-secretase and γ-secretase to produce Aβ₄₂ peptides, which aggregate into extracellular amyloid plaques. Intracellularly, hyperphosphorylated tau protein forms neurofibrillary tangles. The disease progresses from the entorhinal cortex and hippocampus (accounting for early memory loss) to the neocortex. In Parkinson disease, α-synuclein aggregates form Lewy bodies in dopaminergic neurons of the substantia nigra pars compacta, producing the classic tetrad of resting tremor, rigidity, bradykinesia, and postural instability. Huntington disease results from a CAG trinucleotide repeat expansion in the huntingtin gene on chromosome 4, producing a polyglutamine tract that causes aggregation and selective degeneration of the caudate nucleus, leading to chorea and dementia with anticipation across generations.

Demyelinating Diseases

Demyelinating diseases are characterized by the destruction of myelin sheaths with relative preservation of axons. Multiple sclerosis (MS) is the prototypical CNS demyelinating disease, presenting in young women with relapsing-remitting neurological deficits separated in time and space. Histologically, MS plaques show perivenular inflammation with T-cell and macrophage infiltration, oligodendrocyte loss, and reactive gliosis. MRI reveals periventricular white matter lesions (Dawson fingers) that are hyperintense on T2/FLAIR sequences. CSF analysis shows oligoclonal bands and elevated IgG index. Guillain-Barré syndrome (GBS) is the PNS counterpart — an acute inflammatory demyelinating polyneuropathy presenting with ascending paralysis and areflexia, often following a Campylobacter jejuni infection, with CSF showing albuminocytologic dissociation (elevated protein, normal cell count).

CNS Neoplasms

CNS tumors are classified by cell of origin, WHO grade (I–IV), and molecular markers. In adults, the most common primary brain tumor is glioblastoma multiforme (GBM), a WHO grade IV astrocytoma characterized by pseudopalisading necrosis, microvascular proliferation, and a butterfly pattern when crossing the corpus callosum. The most common primary brain tumor in children is pilocytic astrocytoma (WHO grade I), classically located in the cerebellum with Rosenthal fibers and eosinophilic granular bodies on histology. Meningiomas are the most common overall intracranial tumor (arising from arachnoid cap cells, not brain parenchyma) and show psammoma bodies and a whorled pattern. In adults, metastases to the brain (lung, breast, melanoma, renal cell, colon) are actually more common than primary tumors and tend to occur at the gray-white matter junction.

Major Categories of Neuropathology

Worked Example — Clinical-Pathological Correlation

The following worked example demonstrates the systematic approach to a USMLE-style neuropathology vignette. The key skill being tested is your ability to integrate clinical presentation, anatomical localization, and histopathological findings to arrive at a specific diagnosis.

Key Comparisons & Differentials

Epidural vs. Subdural Hematoma

Vasogenic vs. Cytotoxic Edema

Connections to Advanced Neuropathology & Clinical Medicine

The foundational neuropathology covered in this lesson connects directly to advanced clinical reasoning tested in Step 2 CK and encountered in clinical rotations. Understanding the molecular basis of these diseases opens the door to appreciating modern therapeutic strategies and ongoing research. This section bridges the gap between board-level pathology and the clinical-translational frontier.

An increasingly important concept in modern neuropathology is the idea that neurodegenerative diseases may propagate through prion-like spread — that is, misfolded proteins such as tau, α-synuclein, and TDP-43 can template the misfolding of their normal counterparts and spread along neuronal circuits, even though they are not truly infectious in the way PrP^Sc is. This unifying framework, known as the "proteopathy" hypothesis, has profound implications for developing disease-modifying therapies that could halt propagation at early stages. While this level of detail is beyond Step 1, understanding the general principle of protein misfolding as a shared mechanism prepares you for clinical reasoning in neurology.

Practice Problems

Neuropathology — Summary Review